KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 2,810.00
+130.00 (4.85%)
At close: Oct 16, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 54.57 billion as of October 16, 2026. It is the 32,131st most valuable company in the world and the 1,783rd biggest in South Korea. Its market cap has decreased by 48.53% in one year.
Market Cap
54.57B
Enterprise Value
39.87B
Revenue
75.41B
Global Rank
Country Rank
#1,783 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 54.57B, a decrease of -88.94%. That is a compound annual growth rate of -31.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 54.57B | -50.96% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 66.57B |
| IMGT Co.,Ltd. | 65.70B |
| PanGen Biotech | 64.26B |
| ABION | 60.91B |
| ADBiotech | 58.08B |
| Psomagen | 56.36B |
| TegoScience | 55.09B |
| NovMetaPharma | 54.06B |